• Powered by Crown Equity Holdings Inc.
      • crown-logo

        Crown Equity Holdings Inc. is publicly traded with the symbol CRWE. The Company primarily provides and offers advertising, branding, marketing solutions and services to boost customer awareness, as well as merchant visibility as a worldwide online multi-media publisher. For list of services offered click here

Post on CRWE World Login
logo UNITED STATES
  • Home
  • News
  • World
      • World News
      • Español
  • Politics
      • U.S. Legislators
      • Political News
  • Sports
  • Business
      • Markets
      • Hottest Stocks Today
      • CRWEWorld Stocks
      • Blockchain
      • Regulatory
      • Accounting
      • Fundraising Campaigns
      • IPOs
      • Money
      • Career
  • Tech
      • Tech
      • Science
  • Living
      • Arts & Entertainment
      • Family
      • Food
      • Pets
      • Seniors
      • Fashion/Fitness
      • Home & Garden
  • Health
      • Health
      • Pharma & Biotech
  • Opinion
      • Finance
      • Law
      • Healthcare
      • Cannabidiol (CBD)
      • Fashion
      • Podcasts
      • Tech
      • Music
  • Travel
  • Local
      • News
      • Trending Now
      • Real Estate
      • Coupons & Deals
      • Business Directory
  • Jobs
  • More
      • Business 2 Business
      • Press Releases
      • Press Releases Pricing
      • News from GlobeNewswire
      • News from PR Newswire
      • News from Business Wire
      • News from Accesswire
      • Video Channels
      • Beauty
      • Business
      • Comedy
      • Entertainment
      • Fashion
      • Featured
      • Health
      • Instructional
      • News
      • Politics
      • Sports
      • Technology
      • Entertainment
      • Horoscope
      • Sudoku
      • Crossword
      • Games
      • Chat
      • Affiliate | How It Works
      • Join CRWE WORLD Affiliate Program
      • CRWE WORLD Advertising Services Rate
      • Crown Equity Holdings' Overview
      • CRWEWorld Real-Time Global Visitors
      • Content Delivery Solution
        • Contact Us
  • More

Change City


-- OR --
load
load
/assets/img/hottest3.png
/assets/img/hottest2.png

/assets/img/reef2.png
/assets/img/red-line.jpg
/assets/img/reef.png
  • Home
  • Articles
  • News Provided by PR Newswire
21ьз╕ Cweather-icon
/assets/img/hottest3.png
/assets/img/hottest2.png

/assets/img/reef2.png
/assets/img/red-line.jpg
/assets/img/reef.png

Bruker Announces Unique New NMR and MS Tools at Metabolomics 2018

News Provided by PR Newswire2018-06-25
11 Views

Bruker Announces Unique New NMR and MS Tools at Metabolomics 2018

- Novel High-throughput NMR and MS Solutions for Translational Phenomics Research and Biobanking
- NMR quantification of metabolites and lipoprotein subclass analysis now in one measurement

 
[25-June-2018]
 

SEATTLE, June 25, 2018 /PRNewswire/ -- At Metabolomics 2018 (metabolomics2018.org), Bruker today announced B.I.QUANT-PS™, a metabolite quantification solution on its AVANCE IVDr™ 600 MHz NMR platform, which brings cost-effective nuclear magnetic resonance (NMR) screening to high-throughput, translational phenomics research and biobank metabolic analysis.  The novel B.I.QUANT-PS delivers automatic quantification of 26 disease-relevant metabolites and in the same experiment also enables lipoprotein subclass analysis.  In addition, the NMR reference spectral base for pure compounds in biofluids, BBIOREFCODE, has been expanded to cover 800 compounds and >23.500 high quality NMR spectra.  

The transferability and reproducibility of B.I.QUANT-PS was proven as part of an 11 instrument ring test in the International Phenome Center Network (IPCN).  Metabolites providing information on liver, kidney and cardiovascular diseases are now accessible in a fast and fully validated analysis under DIN-ISO wet spiking.

Extract from B.I.BioBankTool analysis report

B.I.QUANT-PS is also an integral part of the new B.I.BioBankTool™ , a solution for biobanks that addresses their increasing need for standardization and quality control (QC).  The B.I.BioBankTool QC procedure delivers information on pre-analytics, sample preparation and analytical performance.  It gives information on matrix identity and integrity, e.g. for urine, EDTA-plasma, citrate plasma or serum, and it can flag sample degradation.  It also confirms fasting/non-fasting, identifies contaminations, as well as reported or unreported medications.  The B.I.BioBankTool can generate quantitative information on 150 metabolites in urine, and >140 lipoprotein and small molecule parameters in plasma/serum.  Retrospective analysis of previously recorded data is feasible.

Professor Matthias Nauck, Director of the Institute for Clinical and Laboratory Medicine at Medical University of Greifswald, commented: "We are excited about the possibilities of NMR screening in biobank quality control to deliver standardized analytical data for biobank metadata.  Having multiple biobanks on the same NMR standards will create a wealth of data from all over the world for integration in support of the development of efficient epidemiological and diagnostic tools.  The addition of B.I.QUANT-PS substantially enhances the value of data generated, and the IVDr platform can replace conventional analysis tools, which alleviates the cost pressures in clinical analysis.  We just installed our AVANCE IVDr at Greifswald University Hospital and will rapidly expand our analytical offerings to biobanks, and for projects such as the German National Cohort."

Bruker also offers novel mass spectrometry-based tools for next-generation metabolomics and translational phenomics research and validation:

Bruker has just announced the revolutionary scimaX™ MRMS (magnetic resonance mass spectrometer) with extreme mass resolution exceeding twenty million, which allows the determination of isotope fine structure (IFS) to determine elemental formulae in complex mixtures without liquid chromatography. The scimaX is based on novel conduction-cooled Maxwell™ magnet technology, essentially making the magnet 'invisible' by eliminating the need for liquid cryogens.  Powered by MetaboScape 4.0® software, the scimaX now offers a novel workflow of flow injection analysis (FIA) MRMS for large cohort, high-throughput phenomics studies, allowing analysis of ~200 samples per day.  

Bruker’s scimaX™ MRMS magnetic resonance mass spectrometer

MetaboScape 4.0 also forms an integral part of our impact-II ultra-high resolution QTOF platform.  Dr. Mathew R. Lewis, COO, MRC-NIHR National Phenome Center, Faculty of Medicine at Imperial College London, stated: "The sensitivity and precision were beyond what I expected, and robustness trials have yielded encouraging results for biofluid profiling. MetaboScape and TASQ software are practical and feature-rich – well suited to the extraction and analysis of data. The total package looks like a real 'Phenomics Workhorse'."

Novel algorithms inMetaboScape 4.0 now also enable the processing of 4D TIMS-separated LC-MS/MS data from Bruker's revolutionary timsTOF™ platform.  This harnesses the information derived from reproducible, accurate Collisional Cross Section (CCS) values of target compounds, allows to dig deeper into the dark metabolome.  This unique CCS capability is a new parameter in the visual 'Annotation Quality Scoring' feature for confidence in compound ID, or characterization of known unknowns.

Bruker’s timsTOF Pro mass spectrometer

Professor Lloyd Sumner, University of Missouri in Columbia, MO, said: "The innovative technology of our timsTOF Pro instrument has enabled us to compile a library of CCS values for many plant metabolites. This additional CCS information can be searched and ultimately increases our final confidence in metabolite identifications."

To learn more, please join our informative lunch symposium at the Metabolomics Society Conference on Tuesday, June 26th, 2018.  Guest speakers Dr. Lloyd Sumner of the University of Missouri and Dr. Matthew Lewis of Imperial College London will present some of their most recent research.

About Bruker Corporation (NASDAQ: BRKR)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.

For more information, please visit: www.bruker.com.

 

Media Contact:   

Investor Contact:

Dr. Thorsten Thiel   

Miroslava Minkova

VP of Group Marketing

Director of Investor Relations & Corporate Development

Bruker BioSpin Group   

Bruker Corporation

T: +49 (721) 5161–6500     

T: +1 (978) 663-3660, ext. 1479

E: thorsten.thiel@bruker.com   

E: miroslava.minkova@bruker.com

Bruker Corporation Logo

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/bruker-announces-unique-new-nmr-and-ms-tools-at-metabolomics-2018-300671104.html

SOURCE Bruker Corporation


Company Codes: NASDAQ-NMS:BRKR


© 2018 PR Newswire. All Rights Reserved.

#content-news .main-news{color:#737373;font-size:14px;line-height:inherit;text-align:inherit}

The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.


Tesla (Nasdaq: TSLA) Announces Date for First Quarter 2021 Financial Results and Webcast



/assets/img/cw-stocks.png

/assets/img/wysh-jewels.png

/assets/img/hjli.png

/assets/img/Mars-Parachute-2.png

/assets/img/crweworld-podcast.jpg
Sponsored
Also read
Addex to Present at the 20th Annual Needham Virtual Healthcare Conference
SIKA EXPLOITS FURTHER GROWTH POTENTIAL IN QATAR
Fagron realizes turnover of € 134.8 million
FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications
Sanofi declares the Offer for Kiadis unconditional
Sodexo Inc successfully completes inaugural US dollar bond issue of $1.25 billion
TGS Q1 2021 Earnings Update
Infor Promotes Becky Xie to Lead Greater China and Korea Region


Post on CRWE WorldSign Up for Free E-mail Updates
  • Real Estate Eagle Firm, Real Estate
  • Hancock Jaffe Laboratories, Nasdaq:HJLI, HJLI
Signup for free email updates
/assets/img/wall-street-rect2.png
/assets/img/wall-street-sq.png



Join with us
Live Traffic Feed
About CrweWorld
  • About Us
  • Privacy Policy
  • Terms & Conditions
  • Finance Disclaimer
  • Jobs
Subscribe for newsletter
3+2
Contact Info
  • contact@crweworld.com

  • P: (702) 683-8946

  • P: (702) 810-0178

  • 11226 Pentland Downs St, Las Vegas, NV 89141

Tweets by CrweWorld
Tweets by @CrweWorld
  • © 2021 crweworld.com
ad1

/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

/assets/images/ad/content-delivery-solution.jpg

 

Our content delivery solution through CRWE WORLD, CRWE Press Release and CRWE Tube gives corporations and businesses a vehicle to expand their exposure

CLICK HERE FOR MORE INFORMATION

ad3

/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

/assets/images/ad/crwetube.png

Share your videos. Upload your videos for free on CRWETube

www.CRWETube.com

ad5

/assets/images/ad/ad4.png

 

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

Advertisements

/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

/assets/images/ad/content-delivery-solution.jpg

 

Our content delivery solution through CRWE WORLD, CRWE Press Release and CRWE Tube gives corporations and businesses a vehicle to expand their exposure

CLICK HERE FOR MORE INFORMATION

/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

/assets/images/ad/crwetube.png

Share your videos. Upload your videos for free on CRWETube

www.CRWETube.com

/assets/images/ad/ad4.png

 

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

CRWE WORLD Advertising Services RateJoin CRWE WORLD Affiliate Program